跳至主要内容
临床试验/DRKS00031503
DRKS00031503招募中不适用

Assessment of clinical, virological and immunological characteristics in high-risk COVID-19 patients with mild to moderate symptoms – a non-interventional cohort study - COVIMAC

Charité Universitätsmedizin Berlin, Klinik m.S. Infektiologie und Pneumologie0 个研究点目标入组 225 人开始时间: 2023年4月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
225

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Proven infection with SARS-CoV-2 (positive PCR testing) with mild to moderate symptoms according to WHO criteria.
  • Symptoms since = 5 days or first positive SARS-CoV-2 PCR = 5 days.
  • Treatment in ambulatory care or concomitant hospitalization for another medical condition.
  • Ability and willingness to participate in the study.
  • Recommendation for preventive treatment with antivirals and/or mABs according to the standard procedure within Charité - Universitätsmedizin Berlin due to present risk-factors for a severe course of COVID-19 (as currently defined by Robert-Koch institute) and one of the following conditions:
  • not vaccinated or not completely vaccinated or high risk for vaccination failure according to the definition by Robert-Koch Institute.

排除标准

  • Inability or unwillingness to provide informed consent.
  • Any conditions that prohibits supplemental blood-sampling.
  • Severe or critical COVID-19 with the need of oxygen supplementation (NIH definition: need of SpO2 <94% on room air, a ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) <300 mm Hg, a respiratory rate >30 breaths/min, or lung infiltrates >50% or in respiratory failure.
  • Patients with planned or performed operation with intubation anestesia.

研究者

发起方
Charité Universitätsmedizin Berlin, Klinik m.S. Infektiologie und Pneumologie

相似试验